The CEO said both Ebola awards were competitive. CDC’s record says one was sole-source.
XpresTest received $38.8 million in obligated federal awards after a Trump-sons-linked fund invested in its parent; the records do not show that either son influenced an award.
Federal records complicate a key defense of XpresTest’s recent Ebola contracts. The company’s chief executive told ProPublica that both federal awards were competitive. The Centers for Disease Control and Prevention’s public notice describes its award as a sole-source acquisition justified by unusual and compelling urgency.
ProPublica reported on Nov. 9 that XpresTest received a $20 million State Department cooperative agreement and an $18.8 million CDC contract after American Ventures invested in its parent, XWELL. USAspending shows $38.8 million obligated across the two awards. The CDC contract carries a potential value of $35.5 million; that ceiling is not money already paid.
The State Department told ProPublica that its separate award followed a competitive process. CDC did not respond to the outlet’s questions. CDC’s own justification cites Federal Acquisition Regulation 6.302-2 and says Ebola outbreaks created an urgent need for airport screening, staffing and related public-health work.
The urgency is real, and XpresTest had relevant domestic airport-surveillance experience. ProPublica also reported that the company had not previously worked on Ebola or overseas biosecurity. Chief executive Ezra Ernst called the Congo work new and risky and said he was unsure the company could complete it.
The financial link is documented but indirect. SEC filings show that American Ventures’ XWELL vehicle holds shares and that Dominari controls the vehicle’s manager and investment manager. Donald Trump Jr. and Eric Trump are Dominari advisers; separate filings report that each held 1,398,414 Dominari shares, or 5.77 percent. That connection is not evidence that either man intervened in procurement.
The contracts can benefit the investment. ProPublica reported that American Ventures invested $30 million in XWELL in February, when Ernst said the company had been close to bankruptcy. In August, American Ventures agreed to sell its stake for about $13 million. Ernst said the federal contracts affected the sale price and could produce additional payments from the buyer.
There is substantial contrary evidence to any claim of proven favoritism. A spokesperson for the Trump sons said they were passive minority investors with no involvement in or knowledge of the contracts and that no law was broken. Dominari’s chief executive said neither son’s family name was used to influence the awards. The records reviewed by Public Rot do not show agency contact by either son, selection based on the family tie, or illegality.
The narrow accountability question is what capability, conflict and scoring review each agency performed. The CDC notice reviewed by Public Rot gives the urgency rationale but no comparative capability analysis; the USAspending grant page does not disclose State’s scoring. Publishing those records would let the public distinguish a fast emergency choice from an unexplained advantage.
The evidence record
Source claimThe fresh ProPublica report, Ernst’s competition claim, State’s response, CDC’s nonresponse, company experience, investment sequence, sale terms and quoted defenses.
Article paragraphs: 1, 2, 3, 4, 6, 7
Source claimState award amount, timing, recipient and purpose.
Article paragraph: 2
Source claimCDC obligated and potential amounts, timing and Ebola entry-screening purpose.
Article paragraph: 2
Source claimCDC characterized the acquisition as sole-source under FAR 6.302-2 and documented unusual and compelling urgency.
Article paragraphs: 1, 3
Source claimThe investment vehicle’s XWELL holdings and Dominari’s control of its management entities.
Article paragraph: 5
Source claimDonald Trump Jr.’s reported Dominari position; the parallel Eric Trump position and both advisory roles were also independently retrieved by the reviewer from the cited SEC filing set and ProPublica.
Article paragraph: 5
AnalysisThe absence of identified intervention or illegality in the reviewed record and the bounded request for capability, conflict and scoring records.
Article paragraphs: 5, 7, 8
Public Rot distinguishes documented financial ties from procurement influence, which the reviewed public records do not establish, and compares the disclosures present in the CDC notice and USAspending pages with the process records that remain undisclosed.
Sources and access
Each source record identifies its reporting origin, access scope and the date we checked it.
How Trump’s Sons Profited From a Company That Landed Nearly $40 Million in Federal Contracts
ProPublica · Checked November 9, 2026
- Recorded relationship
- original
- Origin
- ProPublica
- Access
- Full text
- Locator
- Nov. 9 publication line; sections describing both awards, procurement responses, company experience, investment and sale terms, and all quoted defenses.
- Source publication
- November 9, 2026
Investigative report used as the fresh hook; key award and ownership facts were independently checked against federal records.
State Department cooperative agreement to XpresTest
USAspending.gov · Checked November 9, 2026
- Recorded relationship
- original
- Origin
- U.S. Department of State / USAspending.gov
- Access
- Full text
- Locator
- Award overview: recipient, $20,000,000 obligated, Sept. 25 action, Sept. 28 start and outbreak-response description.
- Source publication
- September 25, 2026
Official federal award record; the displayed outlay was zero at review time.
CDC Ebola entry-screening contract to XpresTest
USAspending.gov · Checked November 9, 2026
- Recorded relationship
- original
- Origin
- Centers for Disease Control and Prevention / USAspending.gov
- Access
- Full text
- Locator
- Award overview and transaction history: $18,815,410.68 obligated, $35,536,326.68 potential value, July 6 start and Sept. 25 within-scope modification.
- Source publication
- July 6, 2026
CDC sole-source notice for Ebola entry screening
SAM.gov · Checked November 9, 2026
- Recorded relationship
- original
- Origin
- Centers for Disease Control and Prevention / SAM.gov
- Access
- Full text
- Locator
- Notice description identifying a sole-source acquisition under FAR 6.302-2 and explaining the outbreak, airport-screening and staffing urgency.
- Source publication
- July 28, 2026
XWELL Schedule 13D/A
U.S. Securities and Exchange Commission · Checked November 9, 2026
- Recorded relationship
- original
- Origin
- American Ventures XWELL SPV LLC / U.S. Securities and Exchange Commission
- Access
- Selected excerpt
- Locator
- Reporting-person and ownership sections identifying the XWELL vehicle and Dominari-controlled manager and investment manager entities.
- Source publication
- October 15, 2026
SEC XML record; relevant ownership fields were checked, not every exhibit.
Dominari Holdings Schedule 13G for Donald Trump Jr.
U.S. Securities and Exchange Commission · Checked November 9, 2026
- Recorded relationship
- original
- Origin
- Donald J. Trump Jr. / U.S. Securities and Exchange Commission
- Access
- Full text
- Locator
- Item 4 ownership table reporting 1,398,414 shares and 5.77 percent.
- Source publication
- October 20, 2026
Prepared with AI research and writing tools. Sources and evidence are listed below. Public Rot is responsible for the published account. The cover is an AI-generated editorial illustration.
Revision record
Revision 1 · November 9, 2026
Initial publication.
These are the recorded publication notices. Open reader tools, full available revisions or report a possible error →